Cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
C19H21N5O4 — CID 152566135
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
Cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate (PubChem CID 152566135) has the molecular formula C19H21N5O4 and a molecular weight of 383.41 g/mol. Its IUPAC name is cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate.
Molecular Properties
| Compound Name | Cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate |
|---|---|
| PubChem CID | 152566135 |
| Molecular Formula | C19H21N5O4 |
| Molecular Weight | 383.41 g/mol |
| Exact Mass | 383.16 |
| IUPAC Name | cyanomethyl (2S)-3-(2-cyano-3-methylbenzimidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate |
| SMILES | Cn1c(C#N)nc2ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)OCC#N)cc21 |
| InChI | InChI=1S/C19H21N5O4/c1-19(2,3)28-18(26)23-14(17(25)27-8-7-20)9-12-5-6-13-15(10-12)24(4)16(11-21)22-13/h5-6,10,14H,8-9H2,1-4H3,(H,23,26)/t14-/m0/s1 |
| InChIKey | YQNFBRUDQSMATP-AWEZNQCLSA-N |
| XLogP | 1.95 |
| TPSA | 130.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 383.41 |
| LogP ≤ 5 | 1.95 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152566135 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.